However, as with all relatively new medications, very long-term safety data (over many years or decades) continues to be gathered through post-marketing surveillance and ongoing research
Key takeaway Depression and anxiety are not listed as common side effects of Mounjaro, and the FDA's January 2026 safety review found no evidence that GLP-1 medications, including tirzepatide, increase the risk of suicidal thoughts or behaviour
Dose titration periods During titration, when you are gradually increasing your dose to manage side effects and find the optimal level, avoid prefilling large batches
Los autores concluyeron: los datos indican que, en pacientes con EP no tratados, GSH tiene eficacia sintomtica y posiblemente retrasa la progresin de la enfermedad.
As of February this year, there were 35 GLP - 1 oral small - molecule pipelines in the clinical stage, accounting for about 20% of all GLP - 1 pipelines under R & D